View ValuationValiantLtd 将来の成長Future 基準チェック /26ValiantLtd利益と収益がそれぞれ年間26.9%と12.7%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に7.5% 26.6%なると予測されています。主要情報26.9%収益成長率26.64%EPS成長率Chemicals 収益成長30.6%収益成長率12.7%将来の株主資本利益率7.55%アナリストカバレッジLow最終更新日27 Apr 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • May 20High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Lianbo Zhang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2026Valiant Co.,Ltd, Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong Chinaお知らせ • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026お知らせ • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026お知らせ • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025お知らせ • Jul 02Valiant Co.,Ltd to Report First Half, 2025 Results on Aug 22, 2025Valiant Co.,Ltd announced that they will report first half, 2025 results on Aug 22, 2025お知らせ • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.お知らせ • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2025Valiant Co.,Ltd, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong Chinaお知らせ • Mar 31Valiant Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025お知らせ • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2024 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report fiscal year 2024 results on Apr 25, 2025Buy Or Sell Opportunity • Nov 13Now 20% undervaluedOver the last 90 days, the stock has risen 28% to CN¥11.55. The fair value is estimated to be CN¥14.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 63% in the next 2 years.Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.089 (vs CN¥0.20 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.089 (down from CN¥0.20 in 3Q 2023). Revenue: CN¥806.3m (down 27% from 3Q 2023). Net income: CN¥80.7m (down 57% from 3Q 2023). Profit margin: 10.0% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings.Buy Or Sell Opportunity • Oct 16Now 20% undervaluedOver the last 90 days, the stock has risen 6.1% to CN¥9.71. The fair value is estimated to be CN¥12.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 51% in the next 2 years.お知らせ • Sep 30Valiant Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Valiant Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.15 per share.Reported Earnings • Aug 22Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 2Q 2023). Revenue: CN¥1.02b (down 2.2% from 2Q 2023). Net income: CN¥116.9m (down 45% from 2Q 2023). Profit margin: 12% (down from 20% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.お知らせ • Jun 29Valiant Co.,Ltd to Report First Half, 2024 Results on Aug 22, 2024Valiant Co.,Ltd announced that they will report first half, 2024 results on Aug 22, 2024Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.お知らせ • Apr 21Valiant Co.,Ltd, Annual General Meeting, May 16, 2024Valiant Co.,Ltd, Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong ChinaReported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥937.9m (down 9.2% from 1Q 2023). Net income: CN¥98.3m (down 44% from 1Q 2023). Profit margin: 11% (down from 17% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.お知らせ • Mar 30Valiant Co.,Ltd to Report Q1, 2024 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report Q1, 2024 results on Apr 20, 2024Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.78, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.お知らせ • Dec 30Valiant Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 3Q 2022). Revenue: CN¥1.10b (down 12% from 3Q 2022). Net income: CN¥186.1m (up 22% from 3Q 2022). Profit margin: 17% (up from 12% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.お知らせ • Oct 19Valiant Co.,Ltd Announces Board AppointmentsValiant Co.,Ltd held its 2nd Extraordinary General Meeting of 2023 on 17 October 2023, approved the appointment of Zhu Caifei and Zhang Yun as non-independent directors.Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.29 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2022). Revenue: CN¥1.04b (down 14% from 2Q 2022). Net income: CN¥212.8m (down 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Board Change • Jul 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. 2 highly experienced directors. Member of Supervisory Board Zhenjian Gu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Jul 23Valiant Co.,Ltd Approves Board ElectionsValiant Co.,Ltd at its Extraordinary General Meeting held on 20 July 2023 approved the election of Tang Meng, Yang Yaowu and Yang Xiaoyue as non-independent directors.Buying Opportunity • Jul 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.5%. The fair value is estimated to be CN¥21.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.お知らせ • Jul 01Valiant Co.,Ltd to Report First Half, 2023 Results on Aug 19, 2023Valiant Co.,Ltd announced that they will report first half, 2023 results on Aug 19, 2023Buying Opportunity • Jun 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 9.4%. The fair value is estimated to be CN¥20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.お知らせ • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.Buying Opportunity • May 16Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 64% in the next 2 years.Reported Earnings • Apr 24First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥1.03b (down 25% from 1Q 2022). Net income: CN¥176.6m (down 24% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥18.82, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 3 highly experienced directors. Member of Supervisory Board Tianxiao Hu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.21 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.26b (down 11% from 3Q 2021). Net income: CN¥153.0m (down 20% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 21Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.19 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.29 (up from CN¥0.19 in 2Q 2021). Revenue: CN¥1.22b (up 19% from 2Q 2021). Net income: CN¥258.1m (up 53% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.Board Change • May 29High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ying Guo was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.14 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.37b (up 74% from 1Q 2021). Net income: CN¥232.8m (up 77% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year.Board Change • Apr 27High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Director Wei Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 29Full year 2021 earnings released: EPS: CN¥0.69 (vs CN¥0.56 in FY 2020)Full year 2021 results: EPS: CN¥0.69 (up from CN¥0.56 in FY 2020). Revenue: CN¥4.36b (up 49% from FY 2020). Net income: CN¥626.7m (up 24% from FY 2020). Profit margin: 14% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 26%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.Buying Opportunity • Feb 12Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥26.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Buying Opportunity • Jan 26Now 21% undervaluedOver the last 90 days, the stock is up 1.6%. The fair value is estimated to be CN¥26.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Valuation Update With 7 Day Price Move • Nov 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 173% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.03 per share.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.15 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥1.42b (up 101% from 3Q 2020). Net income: CN¥191.5m (up 45% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥17.55, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.58 per share.Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥21.52, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 169% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.22 per share.Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.10 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.02b (up 77% from 2Q 2020). Net income: CN¥169.3m (up 84% from 2Q 2020). Profit margin: 17% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.56, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 140% over the past three years.Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.14 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥786.7m (up 18% from 1Q 2020). Net income: CN¥131.8m (up 6.1% from 1Q 2020). Profit margin: 17% (down from 19% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Mar 26Full year 2020 earnings released: EPS CN¥0.56 (vs CN¥0.56 in FY 2019)The company reported a solid full year result with improved revenues, although earnings and profit margins were flat. Full year 2020 results: Revenue: CN¥2.92b (up 1.7% from FY 2019). Net income: CN¥504.7m (flat on FY 2019). Profit margin: 17% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 14% per year.Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥17.10, the stock is trading at a trailing P/E ratio of 31.7x, down from the previous P/E ratio of 37.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 60%.Is New 90 Day High Low • Mar 06New 90-day low: CN¥18.68The company is down 6.0% from its price of CN¥19.95 on 04 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.16 per share.Is New 90 Day High Low • Jan 25New 90-day high: CN¥24.71The company is up 36% from its price of CN¥18.17 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.14 per share.Is New 90 Day High Low • Jan 07New 90-day high: CN¥22.27The company is up 18% from its price of CN¥18.89 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.89 per share.Is New 90 Day High Low • Dec 21New 90-day high: CN¥21.29The company is up 13% from its price of CN¥18.82 on 23 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.46 per share.Is New 90 Day High Low • Dec 03New 90-day high: CN¥20.51The company is up 10.0% from its price of CN¥18.66 on 04 September 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.08 per share.Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥488.8m, down 3.1% from the prior year. Total revenue was CN¥2.88b over the last 12 months, up 5.5% from the prior year.Is New 90 Day High Low • Oct 23New 90-day low: CN¥16.38The company is down 1.0% from its price of CN¥16.55 on 24 July 2020. The Chinese market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥26.87 per share.お知らせ • Oct 17Valiant Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020Valiant Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020お知らせ • Jul 18Valiant Co.,Ltd to Report First Half, 2020 Results on Aug 15, 2020Valiant Co.,Ltd announced that they will report first half, 2020 results on Aug 15, 2020業績と収益の成長予測XSEC:002643 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20285,463668N/AN/A112/31/20274,929570N/A987312/31/20264,299512N/A1,18923/31/20263,8712924411,099N/A12/31/20253,7172843961,090N/A9/30/20253,7572563041,084N/A6/30/20253,607249961,016N/A3/31/20253,617228-25954N/A12/31/20243,693246-121,096N/A9/30/20243,892484-1171,244N/A6/30/20244,188589-1841,239N/A3/31/20244,210685-3231,121N/A12/31/20234,305763-3121,084N/A9/30/20234,412653-336929N/A6/30/20234,567620-406893N/A3/31/20234,742665-345979N/A1/1/20235,080721-312983N/A9/30/20224,977778-238942N/A6/30/20225,135816-66939N/A3/31/20224,94372861896N/A1/1/20224,3596273131,045N/A9/30/20214,1936493031,067N/A6/30/20213,481589135870N/A3/31/20213,036512-29713N/A12/31/20202,918505-100559N/A9/30/20202,87748960670N/A6/30/20202,824492219858N/A3/31/20202,87753088780N/A12/31/20192,870507N/A757N/A9/30/20192,725505N/A664N/A6/30/20192,647482N/A507N/A3/31/20192,636482N/A540N/A12/31/20182,632444N/A431N/A9/30/20182,509389N/A425N/A6/30/20182,472364N/A446N/A3/31/20182,502350N/A451N/A12/31/20172,456385N/A612N/A9/30/20172,320370N/A531N/A6/30/20172,221347N/A455N/A3/31/20172,037328N/A308N/A12/31/20161,847319N/A153N/A9/30/20161,933363N/A211N/A6/30/20161,904373N/A276N/A3/31/20161,788324N/A335N/A12/31/20151,631258N/A367N/A9/30/20151,386179N/A315N/A6/30/20151,251130N/A264N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 002643の予測収益成長率 (年間26.9% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 002643の収益 ( 26.9% ) CN市場 ( 27% ) よりも低い成長が予測されています。高成長収益: 002643の収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: 002643の収益 ( 12.7% ) CN市場 ( 16% ) よりも低い成長が予測されています。高い収益成長: 002643の収益 ( 12.7% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 002643の 自己資本利益率 は、3年後には低くなると予測されています ( 7.5 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 20:21終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Valiant Co.,Ltd 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Xiongwei JiaChina International Capital Corporation LimitedChao LiCitic Securities Co., Ltd.Nai Di ZhaoEverbright Securities Co. Ltd.8 その他のアナリストを表示
Board Change • May 20High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Lianbo Zhang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2026Valiant Co.,Ltd, Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
お知らせ • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026
お知らせ • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026
お知らせ • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025
お知らせ • Jul 02Valiant Co.,Ltd to Report First Half, 2025 Results on Aug 22, 2025Valiant Co.,Ltd announced that they will report first half, 2025 results on Aug 22, 2025
お知らせ • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.
お知らせ • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2025Valiant Co.,Ltd, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
お知らせ • Mar 31Valiant Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025
お知らせ • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2024 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report fiscal year 2024 results on Apr 25, 2025
Buy Or Sell Opportunity • Nov 13Now 20% undervaluedOver the last 90 days, the stock has risen 28% to CN¥11.55. The fair value is estimated to be CN¥14.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 63% in the next 2 years.
Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.089 (vs CN¥0.20 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.089 (down from CN¥0.20 in 3Q 2023). Revenue: CN¥806.3m (down 27% from 3Q 2023). Net income: CN¥80.7m (down 57% from 3Q 2023). Profit margin: 10.0% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings.
Buy Or Sell Opportunity • Oct 16Now 20% undervaluedOver the last 90 days, the stock has risen 6.1% to CN¥9.71. The fair value is estimated to be CN¥12.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 51% in the next 2 years.
お知らせ • Sep 30Valiant Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Valiant Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.15 per share.
Reported Earnings • Aug 22Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 2Q 2023). Revenue: CN¥1.02b (down 2.2% from 2Q 2023). Net income: CN¥116.9m (down 45% from 2Q 2023). Profit margin: 12% (down from 20% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
お知らせ • Jun 29Valiant Co.,Ltd to Report First Half, 2024 Results on Aug 22, 2024Valiant Co.,Ltd announced that they will report first half, 2024 results on Aug 22, 2024
Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.
お知らせ • Apr 21Valiant Co.,Ltd, Annual General Meeting, May 16, 2024Valiant Co.,Ltd, Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
Reported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥937.9m (down 9.2% from 1Q 2023). Net income: CN¥98.3m (down 44% from 1Q 2023). Profit margin: 11% (down from 17% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
お知らせ • Mar 30Valiant Co.,Ltd to Report Q1, 2024 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report Q1, 2024 results on Apr 20, 2024
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.78, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.
お知らせ • Dec 30Valiant Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 3Q 2022). Revenue: CN¥1.10b (down 12% from 3Q 2022). Net income: CN¥186.1m (up 22% from 3Q 2022). Profit margin: 17% (up from 12% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
お知らせ • Oct 19Valiant Co.,Ltd Announces Board AppointmentsValiant Co.,Ltd held its 2nd Extraordinary General Meeting of 2023 on 17 October 2023, approved the appointment of Zhu Caifei and Zhang Yun as non-independent directors.
Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.29 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2022). Revenue: CN¥1.04b (down 14% from 2Q 2022). Net income: CN¥212.8m (down 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Board Change • Jul 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. 2 highly experienced directors. Member of Supervisory Board Zhenjian Gu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Jul 23Valiant Co.,Ltd Approves Board ElectionsValiant Co.,Ltd at its Extraordinary General Meeting held on 20 July 2023 approved the election of Tang Meng, Yang Yaowu and Yang Xiaoyue as non-independent directors.
Buying Opportunity • Jul 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.5%. The fair value is estimated to be CN¥21.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.
お知らせ • Jul 01Valiant Co.,Ltd to Report First Half, 2023 Results on Aug 19, 2023Valiant Co.,Ltd announced that they will report first half, 2023 results on Aug 19, 2023
Buying Opportunity • Jun 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 9.4%. The fair value is estimated to be CN¥20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.
お知らせ • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.
Buying Opportunity • May 16Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 64% in the next 2 years.
Reported Earnings • Apr 24First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥1.03b (down 25% from 1Q 2022). Net income: CN¥176.6m (down 24% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥18.82, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.
Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 3 highly experienced directors. Member of Supervisory Board Tianxiao Hu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.21 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.26b (down 11% from 3Q 2021). Net income: CN¥153.0m (down 20% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 21Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.19 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.29 (up from CN¥0.19 in 2Q 2021). Revenue: CN¥1.22b (up 19% from 2Q 2021). Net income: CN¥258.1m (up 53% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.
Board Change • May 29High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ying Guo was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.14 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.37b (up 74% from 1Q 2021). Net income: CN¥232.8m (up 77% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year.
Board Change • Apr 27High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Director Wei Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 29Full year 2021 earnings released: EPS: CN¥0.69 (vs CN¥0.56 in FY 2020)Full year 2021 results: EPS: CN¥0.69 (up from CN¥0.56 in FY 2020). Revenue: CN¥4.36b (up 49% from FY 2020). Net income: CN¥626.7m (up 24% from FY 2020). Profit margin: 14% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 26%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.
Buying Opportunity • Feb 12Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥26.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Buying Opportunity • Jan 26Now 21% undervaluedOver the last 90 days, the stock is up 1.6%. The fair value is estimated to be CN¥26.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 173% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.03 per share.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.15 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥1.42b (up 101% from 3Q 2020). Net income: CN¥191.5m (up 45% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥17.55, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.58 per share.
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥21.52, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 169% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.22 per share.
Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.10 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.02b (up 77% from 2Q 2020). Net income: CN¥169.3m (up 84% from 2Q 2020). Profit margin: 17% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.56, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 140% over the past three years.
Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.14 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥786.7m (up 18% from 1Q 2020). Net income: CN¥131.8m (up 6.1% from 1Q 2020). Profit margin: 17% (down from 19% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Mar 26Full year 2020 earnings released: EPS CN¥0.56 (vs CN¥0.56 in FY 2019)The company reported a solid full year result with improved revenues, although earnings and profit margins were flat. Full year 2020 results: Revenue: CN¥2.92b (up 1.7% from FY 2019). Net income: CN¥504.7m (flat on FY 2019). Profit margin: 17% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 14% per year.
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥17.10, the stock is trading at a trailing P/E ratio of 31.7x, down from the previous P/E ratio of 37.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 60%.
Is New 90 Day High Low • Mar 06New 90-day low: CN¥18.68The company is down 6.0% from its price of CN¥19.95 on 04 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.16 per share.
Is New 90 Day High Low • Jan 25New 90-day high: CN¥24.71The company is up 36% from its price of CN¥18.17 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.14 per share.
Is New 90 Day High Low • Jan 07New 90-day high: CN¥22.27The company is up 18% from its price of CN¥18.89 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.89 per share.
Is New 90 Day High Low • Dec 21New 90-day high: CN¥21.29The company is up 13% from its price of CN¥18.82 on 23 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.46 per share.
Is New 90 Day High Low • Dec 03New 90-day high: CN¥20.51The company is up 10.0% from its price of CN¥18.66 on 04 September 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.08 per share.
Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥488.8m, down 3.1% from the prior year. Total revenue was CN¥2.88b over the last 12 months, up 5.5% from the prior year.
Is New 90 Day High Low • Oct 23New 90-day low: CN¥16.38The company is down 1.0% from its price of CN¥16.55 on 24 July 2020. The Chinese market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥26.87 per share.
お知らせ • Oct 17Valiant Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020Valiant Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020
お知らせ • Jul 18Valiant Co.,Ltd to Report First Half, 2020 Results on Aug 15, 2020Valiant Co.,Ltd announced that they will report first half, 2020 results on Aug 15, 2020